Borderline ovarian tumor - a case report with genetic testing

Area of Science:

• Gynecologic Oncology
• Pathology
• Molecular Biology

Background:

• Borderline ovarian tumors present diagnostic and therapeutic challenges, particularly concerning fertility preservation and recurrence risk.
• Current treatment decisions rely on histopathological features like microinvasion, but a clearer risk stratification is needed.
• Understanding the genetic underpinnings of these tumors is crucial for personalized therapeutic approaches.

Observation:

• A case of serous borderline ovarian tumor with tumor cell dispersion into the gastrointestinal tract was analyzed.
• The expression of tumor vascular markers GPM6B and DR6 was investigated in the patient.
• These markers were compared between the patient and a control group of healthy individuals.

Findings:

• The study identified specific genetic markers (GPM6B, DR6) associated with tumor vascularity in borderline ovarian tumors.
• Analysis of tumor cell dispersion provides insights into potential metastatic pathways.
• Comparative analysis with healthy controls helps establish baseline gene expression patterns.

Implications:

• Identifying high-risk patients through genetic profiling could refine treatment strategies for borderline ovarian tumors.
• This research may lead to more tailored and effective fertility-sparing management.
• Further investigation into these genetic markers could improve patient outcomes and reduce disease recurrence.